Correlation Between Viatris and Sage Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Sage Therapeutic, you can compare the effects of market volatilities on Viatris and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Sage Therapeutic.

Diversification Opportunities for Viatris and Sage Therapeutic

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viatris and Sage is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of Viatris i.e., Viatris and Sage Therapeutic go up and down completely randomly.

Pair Corralation between Viatris and Sage Therapeutic

Given the investment horizon of 90 days Viatris is expected to generate 0.47 times more return on investment than Sage Therapeutic. However, Viatris is 2.13 times less risky than Sage Therapeutic. It trades about 0.06 of its potential returns per unit of risk. Sage Therapeutic is currently generating about -0.07 per unit of risk. If you would invest  1,164  in Viatris on September 12, 2024 and sell it today you would earn a total of  87.00  from holding Viatris or generate 7.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Sage Therapeutic

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Sage Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sage Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Viatris and Sage Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Sage Therapeutic

The main advantage of trading using opposite Viatris and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.
The idea behind Viatris and Sage Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years